Dokumente
Europa English Court of Justice of the European Union CJEU
07.03.2024
Judgment
#ECLI:EU:C:2024:179
European Court of Justice 

Doctipharma

Provisional text JUDGMENT OF THE COURT (Second Chamber)29 February 2024 (*)(Reference for a preliminary ruling – Medicinal products for human use – Directive 2001/83/EC – Article 85 c – Scope – Distance selling to the general public of medicinal products – Medicinal products for human use not subject to compulsory medical prescription – Persons authorised or entitled to engage in distance selling to the general public of medicinal products – Power of the Member States to impose conditions, ju...
Provisional text JUDGMENT OF THE COURT (Second Chamber)29 February 2024 (*)(Reference for a preliminary ruling – Medicinal products for human use – Directive 2001/83/EC – Article 85 c – Scope – Distance selling to the general public of medicinal products – Medicinal products for human use not subject to compulsory medical prescription – Persons authorised or entitled to engage in distance selling to the general public of medicinal products – Power of the Member States to impose conditions, justified by the protection of public health, on the retailing, on their territory, of medicinal products sold online – Information society services – Directive 98/34/EC – Directive (EU) 2015/1535 – Service connecting pharmacists and customers for the online sale of medicinal products)In Case C‑606/21,REQUEST for a preliminary ruling under Article 267 TFEU from the cour d’appel de Paris (Court of Appeal, Paris, France), made by decision of 17 September 2021, received at the Court on 30 September 2021, in the proceedings Doctipharma SASv Union des Groupements de pharmaciens d’officine (UDGPO),Pictime Coreyre,THE COURT (Second Chamber),composed of A. Prechal, President of the Chamber, F. Biltgen, N. Wahl (Rapporteur), J. Passer and M. L. Arastey Sahún, Judges,Advocate General: M. Szpunar,Registrar: K. Hötzel, Administrator,having regard to the written procedure and further to the hearing on 19 April 2023,after considering the observations submitted on behalf of:–        Doctipharma SAS, by...

Angaben ohne Gewähr. Stand: 07.03.2024